Gilead Sciences Inc (GILD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering GILD.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
GILD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Gilead Sciences Inc's number of analysts covering the stock is greater than 97.45% of all US stocks.
- Gilead Sciences Inc's percentage of analysts bullish on the stock is greater than 12.21% of Pharmaceutical Products stocks.
- Gilead Sciences Inc's average analyst price target is greater than 87.32% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of GILD is greater than 84.58% of stocks in the large market cap category.
- GILD has a lower percent of analysts bearish on the stock than 15.67% of Pharmaceutical Products stocks.
- GILD has a less variance in analysts' estimates than 17.39% of all US stocks.
- Gilead Sciences Inc's change in bullishness amongst analysts is lower than just about 100% of all US stocks.
Is GILD a Buy, Hold or Sell? See the POWR Ratings now!